Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
We evaluate which retirement option—index fund or target date fund—fits your timeline, risk profile, and tax strategy for a smoother retirement.
26,044 articlesA healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
When a well-known fund exits a position, it invites scrutiny. This fund dumped million in Graphic Packaging as shares...
Investors are eyeing space stocks, but SpaceX remains private while Rocket Lab trades on the public market. This guid...
A major fund reduced its TransAlta stake in Q4, sparking questions about the stock’s trajectory. This article explain...
A hedge fund quietly pulled the plug on a sizable Cinemark stake after a sharp stock decline. The move, disclosed in ...
A crypto-focused venture outfit scores a $1.2 billion fund rise, signaling a major shift toward AI and robotics along...
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A notable stake in Patterson-UTI Energy raises questions about a possible oil-service rebound. This article dives int...
PNC Bank has closed a $251.4 million affordable housing fund to expand the nation’s supply of affordable rentals, fin...
As the space economy matures, investors face a clear choice between Redwire and Rocket Lab. This guide breaks down bu...
When mortgage markets swung on interest-rate headlines, one fund pressed deeper into PennyMac. This article explains ...
VanEck's GENZ pivots from casino-heavy holdings to growth stocks like Uber and NetEase, reshaping its dividend story ...